Imeik Technology Development Co (300896) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Imeik Technology Development Co (300896) has a cash flow conversion efficiency ratio of 0.032x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥257.61 Million ≈ $37.70 Million USD) by net assets (CN¥8.16 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Imeik Technology Development Co for the company's overall valuation and market capitalisation.
Imeik Technology Development Co - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Imeik Technology Development Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Imeik Technology Development Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imeik Technology Development Co ranked by their cash flow conversion efficiency. Explore Imeik Technology Development Co cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Adata Technology Co Ltd
TWO:3260
|
-0.077x |
|
Beijing New Building Materials Public Ltd Co
SHE:000786
|
0.092x |
|
Co-Tech Development
TWO:8358
|
0.000x |
|
KRONES AG(UNSP.ADR)1/2/ON
F:KRNU
|
0.035x |
|
Travere Therapeutics Inc
NASDAQ:TVTX
|
-0.409x |
|
Liaoning Port Co Ltd
SHG:601880
|
0.032x |
|
Taihan Electric Wire Co Ltd
KO:001440
|
-0.054x |
|
Itron Inc
NASDAQ:ITRI
|
0.054x |
Annual Cash Flow Conversion Efficiency for Imeik Technology Development Co (2014–2025)
The table below shows the annual cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. View 300896 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.16 Billion ≈ $1.19 Billion |
CN¥1.39 Billion ≈ $202.93 Million |
0.170x | -29.93% |
| 2024-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥1.93 Billion ≈ $282.01 Million |
0.242x | -19.55% |
| 2023-12-31 | CN¥6.49 Billion ≈ $948.97 Million |
CN¥1.95 Billion ≈ $285.94 Million |
0.301x | +50.06% |
| 2022-12-31 | CN¥5.95 Billion ≈ $870.05 Million |
CN¥1.19 Billion ≈ $174.71 Million |
0.201x | +7.13% |
| 2021-12-31 | CN¥5.03 Billion ≈ $736.01 Million |
CN¥942.78 Million ≈ $137.96 Million |
0.187x | +99.53% |
| 2020-12-31 | CN¥4.53 Billion ≈ $663.06 Million |
CN¥425.68 Million ≈ $62.29 Million |
0.094x | -79.90% |
| 2019-12-31 | CN¥662.70 Million ≈ $96.97 Million |
CN¥309.72 Million ≈ $45.32 Million |
0.467x | +39.60% |
| 2018-12-31 | CN¥404.74 Million ≈ $59.23 Million |
CN¥135.50 Million ≈ $19.83 Million |
0.335x | +30.60% |
| 2017-12-31 | CN¥328.31 Million ≈ $48.04 Million |
CN¥84.16 Million ≈ $12.32 Million |
0.256x | +23.74% |
| 2016-12-31 | CN¥265.49 Million ≈ $38.85 Million |
CN¥55.00 Million ≈ $8.05 Million |
0.207x | -35.02% |
| 2015-12-31 | CN¥151.66 Million ≈ $22.19 Million |
CN¥48.35 Million ≈ $7.07 Million |
0.319x | +0.43% |
| 2014-12-31 | CN¥88.06 Million ≈ $12.89 Million |
CN¥27.95 Million ≈ $4.09 Million |
0.317x | -- |
About Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more